Archives

by in
Entry Author Date Location
Mello’s RXi Pharma to Raise $8.1M 03/01/11 Boston
EyeGate Adds $6M to Series D 01/06/11 Boston
Alnylam CEO Looks to the Future, Dicerna Plumps Up Kyowa Hakko Pact, Momenta Sells $57.4M Stock Offering, & More Boston-Area Life Sciences News 12/10/10 Boston
Dicerna Expands Kyowa Hakko Pact 12/07/10 Boston
Lilly Funds Cerulean, Genzyme Sells Diagnostics Unit, Roche Ends RNAi Program, & More Boston-Area Life Sciences News 11/19/10 Boston
Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News 10/22/10 Boston
Dicerna Gets Glaxo’s SR One to Join Investor Syndicate 10/21/10 Boston
Alnylam Seeks to Prove RNAi Skeptics Wrong After Layoffs, End of Novartis Deal 10/21/10 Boston
5 Biotech Storylines to Watch in Boston 10/13/10 Boston
ProNAi Therapeutics Advances Gene-Silencing Cancer Drug, Marina Biotech Provides Delivery Package 09/28/10 Detroit
RXi, EyeGate Team Up 09/22/10 Boston
Dicerna Pharma Gets $25M Boost to Develop Next-Gen Gene Silencing Drugs 08/11/10 Boston
New Startup ViThera Labs Aims “Weaponized” Bacteria Drugs at Gut Diseases 08/10/10 Boston
$5M Debt Deal for Dicerna Pharma 06/30/10 Boston
Former J&J Group Chairman’s Firm Backs BIND Biosciences in $12.4M Round 06/29/10 Boston
Doug Fambrough Reduces Role at Oxford Bioscience Partners, Becomes CEO of Portfolio Company Dicerna Pharma 05/06/10 Boston
Avila Gets Leukemia & Lymphoma Society Funding, Dicerna Unites with Ipsen, Rhythmia to Test Heart Mapping Technology, Amag Licenses to Takeda, & More Boston-Area Life Sciences News 04/02/10 Boston
MDRNA and Cequent Pharma in $46M Merger Deal 04/01/10 Seattle
Novell Turns Down Buyout Offer, Alnylam Pulls In $20M from Takeda, $16M Stock Deal Goes to RXi, & More Boston-Area Deals News 03/24/10 Boston
The Decade’s Most Important Biomedical Discovery 12/18/09 Boston
Nobel Laureate from Caltech, RNAi Leader To Headline Xconomy San Diego Event on Monday 12/09/09 San Diego
Mersana Therapeutics Advancing Anti-Tumor Treatment with Novel Drug-Delivery Technology 12/08/09 Boston
Alnylam Eyes RNAi for Manufacturing Drugs 11/12/09 Boston
Alnylam Chief Foresees Another Gene-Silencing Spin-Off, and More News Tidbits from Boston’s MassBio Investors Forum 10/07/09 Boston
Alnylam and Tekmira Seek New Ways to Deliver RNAi Drugs Deep in the Body 08/06/09 Boston
Replacing Phil Sharp Will Be Up to Biogen’s Board 07/20/09 Boston
Novartis Extends Alnylam Deal 07/17/09 Boston
Isis, Alnylam to Collaborate on Single-Stranded RNA Drugs; Deal Could Add Up to $31 Million to Isis’ Coffers 04/29/09 San Diego
Cleaner Water Through Biotech? 349Q Kills Water-Borne Microbes with RNAi 04/27/09 Boston
Alnylam to Receive European Patent 04/20/09 Boston
Page 2 of 4 « previous page · next page »